Literature DB >> 25986229

Gold nanoparticles enhancing protontherapy efficiency.

Lorenzo Torrisi1.   

Abstract

The insertion of gold nanoparticles in biological liquids, tissues and organs permits to increase the equivalent atomic number of the medium that, if used as target to be irradiated by ionizing radiation, permits an increment of the absorbed dose. No toxic nanoparticles, such as the Au, can be injected in the cancer tissues at different concentrations before using a localized treatment that uses energetic proton beams for radiotherapy. Due to the high density and atomic number of the used gold nanoparticles, the absorbed radiation dose can be increased to about a factor six per cent using relatively low concentration of nanoparticles injectable as solution in the tumor tissue. This means to reduce the exposition to ionizing radiation or to increase the dose to the tumor site. Simulation programs of proton energy loss in tissues, using SRIM Code, are employed to evaluate the Bragg peak enhancing in presence of Au nanoparticles, so it will be presented and discussed. Some research findings and patents in the gold nanoparticle preparation and application to Medicine are reviewed in the present paper.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25986229     DOI: 10.2174/1872210509999141222224121

Source DB:  PubMed          Journal:  Recent Pat Nanotechnol        ISSN: 1872-2105            Impact factor:   1.952


  3 in total

Review 1.  Recent Advances in Cancer Therapy Based on Dual Mode Gold Nanoparticles.

Authors:  Ellas Spyratou; Mersini Makropoulou; Efstathios P Efstathopoulos; Alexandros G Georgakilas; Lembit Sihver
Journal:  Cancers (Basel)       Date:  2017-12-19       Impact factor: 6.639

Review 2.  MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders.

Authors:  Dong Han; Xiaoyu Dong; Dongming Zheng; Jianfei Nao
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

3.  Study on the Dose Enhancement of Gold Nanoparticles When Exposed to Clinical Electron, Proton, and Alpha Particle Beams by Means of Geant4.

Authors:  Mehran Mohseni; Arezoo Kazemzadeh; Nafiseh Ataei; Habiballah Moradi; Akbar Aliasgharzadeh; Bagher Farhood
Journal:  J Med Signals Sens       Date:  2020-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.